BlackRock Chief Executive Larry Fink warned company boards to step up efforts to tackle climate change, a significant shift by the world’s top asset manager as it faces mounting concerns about its fossil fuel investments.
Snoop Dogg and Dunkin’ have teamed up for a new Beyond Meat sandwich only available for a limited time. Yahoo Finance’s Zack Guzman, Heidi Chung and Director of Research at QVIDTVM, Inc. Max Raskin discuss on YFi PM. …read more […]
(Bloomberg) — U.S. stocks retreated from all-time highs after Bloomberg reported that existing tariffs on billions of dollars of Chinese goods will likely stay in place after the presidential election.The S&P 500, Nasdaq Composite and Dow Jones Industrial indexes all pulled back from records as the conditions underscored lingering concern about future progress in negotiations. Treasuries climbed earlier after a gauge of underlying inflation rose less than forecast.“There was a lot of optimism built up and now this just throws a whole new wrench into that optimism and a lot of questions moving forward,” said Ryan Nauman, a market strategist …read more […]
As U.S. President Donald Trump and Chinese Vice Premier Liu He prepare to sign a “Phase 1” trade deal, new data show that the costs of Trump’s trade wars are proving more widespread, deeper and longer-lasting than previously believed.
Legalized weed is proving a boon to midwest coffers. Yahoo Finance’s Julie Hyman, Adam Shapiro, Dan Roberts, Constance Hunter KPMG Chief Economist and Stormy Simon High Times CEO discuss. …read more […]
Exact Sciences’ (EXAS) preliminary quarterly results blew expectations out of the water.Yesterday, the molecular diagnostics company released preliminary results for its fourth quarter that exceeded analysts’ estimates. Total revenue for the quarter is expected to land between $294 million and $296 million, reflecting a top-line beat of about $4 million to $6 million.The better-than-expected outcome was primarily driven by its acquisition of Genomic Health, which was finalized back in November and gave it access to Oncotype DX gene expression tests that have been used in treatment decisions for over 1 million cancer patients globally. During the quarter, Oncotype DX test …read more […]
(Bloomberg) — Boeing Co. is talking to a group of banks about a potential loan as it deals with a production halt of its grounded 737 Max jetliners, according to people familiar with the matter.Citigroup Inc. is leading the discussions between Boeing and a small group of banks, said the people, who asked not to be named because the details are confidential. The precise structure and timing of the loan is in flux, but the financing may be an investment-grade term loan, they said.Representatives for Citi and Boeing declined to comment.Boeing’s access to the credit markets could soon get more …read more […]
U.S. stocks eked out gains to hit fresh record highs on Tuesday, as stronger-than-expected earnings from JPMorgan and Citigroup added to optimism about the domestic economy ahead of the imminent signing of a U.S.-China trade deal.
Why was the Ukrainian airliner mistakenly shot down near Tehran by Iranian forces last week for the loss of 176 lives even allowed to take off from a country that had just fired missiles towards its neighbour? And why didn’t the airline just delay or cancel the flight?
A big financial name, a key transport company, and an enterprise cloud company are among the names liked by Ralph Bassett, head of North American equities at Aberdeen Standard Investments. …read more […]
Oil prices climbed on Tuesday after five days of declines as the United States and China prepared to sign a preliminary trade deal and as Middle East tensions eased.
Wells Fargo & Co’s profit slumped 55% in the fourth quarter as new boss Charles Scharf set aside another $1.5 billion for legal costs related to the bank’s sales scandal and promised “fundamental changes.”
Despite trade wars, low interest rates and new geopolitical tensions, big U.S. banks have not experienced major disruption to their core businesses and top executives are hopeful they can generate growth this year.
In a single day, the talk on the Street has zeroed in on one stock, oncology-focused cell therapy company Adaptimmune Therapeutics (ADAP). Following its presentation of promising data at the 38th annual J.P. Morgan Healthcare Conference, shares took off, posting a whopping 200% one-day gain.The data revealed that its MAGE-A4 (ADP-A2M4 and next-generation ADP-A2M4CD8) and AFP (ADP-A2AFP) therapies, part of its SPEAR T-cell platform, demonstrated initial solid tumor responses in four indications: gastro-esophageal junction, head and neck, liver cancers and melanoma.“These responses demonstrate that our proprietary SPEAR T-cell platform is clearly active and can overcome the challenges of treating a …read more […]
Chile’s state-owned Codelco, the world’s largest copper producer, said on Tuesday it had filed a lawsuit over an alleged scam in insurance contracts drawn up by unions for workers at its Chuquicamata and Radomiro Tomic mines.
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
